Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and ...

Vetter has invested approximately $285 million in the new Des Plaines clinical manufacturing site, which is expected to open ...

The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts ...

A membrane transport protein called SLC13A5 has previously been linked to a severe form of epileptic encephalopathy.

When the macrophages’ ability to consume dying cancer cells or Upd3 production was decreased, tumor growth was significantly ...

Iya Khalil, PhD, discusses Merck & Co.’s approach to artificial intelligence (AI), and success in applying the technology, ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle-inspired chip.

Moving toward clinical development, the researchers demonstrated efficient delivery of mRNA mitochondrial base editors using ...

The company has integrated the AI model into its internal discovery pipeline and aims to use it in collaborative drug ...

AI-powered ChemPerturb-seq reveals sex-specific cocktail improving islet transplant survival, offering a new treatment for ...

The SAIR database is designed to help scientists train AI models to better predict protein-ligand binding affinities for drug ...